Indian pharma stocks are rebounding, driven by domestic investors after a period of Foreign Institutional Investor (FII) selling pressure. Uncertainty surrounding potential US tariffs, fueled by Trump s statements and delays in the Bilateral Trade Agreement (BTA), had initially impacted the sector. While FIIs remain cautious, positive earnings reports and the defensive nature of domestic-oriented pharma businesses are attracting DII interest.

On Monday, the rupee strengthened by 9 paise, reaching 86.43 against the US dollar, buoyed by a weaker greenback. However, ongoing US-India tariff negotiations and continuous dollar demand from importers limited the rupee s gains. Brent crude oil prices rose due to developing trade agreements, while investors awaited the US Federal Reserve s policy meeting.

Indian government bonds may face selling pressure on Monday. This is due to cautious sentiment after benchmark bond yield rose. Traders are losing interest after the debt auction. Reserve Bank of India sold bonds, but selling intensified after governor s comments. Rate easing expectations are curbed. Focus shifts to growth and inflation outlook.

Kotak Mahindra Bank s shares plummeted following disappointing Q1 results, revealing a 7% YoY decline in net profit due to asset quality deterioration and margin compression. Brokerages responded with downgrades and target price cuts, citing concerns over return ratios and emerging stress in the retail commercial vehicle segment.

Vijay Kedia s portfolio experienced a Rs 71 crore decline in value this year due to Atul Auto s underperformance, despite Kedia holding a significant 20.91% stake. Experts suggest potential buying opportunities within a specific price range, while also noting the stock s stretched valuation.

Aadhar Housing Finance shares: The proposed investment, valued between $200–225 million (approximately Rs 1,750–2,000 crore), would result in acquiring a 10–12% stake in the affordable housing finance company via a secondary share sale.

Indian Energy Exchange (IEX) shares tumbled nearly 9% after renewed selling pressure over market coupling fears—a regulatory change that threatens its dominance. This follows a brief rally on strong Q1 results. Brokerages slashed targets, citing margin pressure and market share erosion. Analysts warn that IEX s monopoly may be ending as competition rises and pricing power fades.

Swaminathan Aiyar suggests the UK trade agreement is a welcome step amidst rising global trade barriers. While not transformative due to existing low trade, any increase benefits India. Improved conditions for Indian workers in the UK are a key achievement. Exemptions from social security and remote work options enhance earnings. Bilateral trade aims for $120 billion by 2030.

Premier Energies shares: Premier Energies posted a 10% year-on-year increase in revenue, reaching Rs 1,820.7 crore for the quarter ended June. EBITDA jumped 53% to Rs 548.3 crore, while net profit rose 55.4% to Rs 307.8 crore, up from Rs 198.1 crore in the corresponding quarter last year.

Tata Motors shares: The agreement was announced on Sunday by U.S. President Donald Trump and European Commission President Ursula von der Leyen, narrowly avoiding the August 1 deadline that could have triggered a 30% blanket tariff on EU exports to the United States.